La cadena de opciones muestra datos clave de las opciones de acciones de Upexi a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Upexi..

Upexi (NASDAQ:UPXI) Bolsa, Cadena de Opciones

Upexi

Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.

Upexi Inc

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) with a Buy and maintains $221 price target.

News

Price Target

Reiteration

Analyst Ratings

KRYS

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $221 Price Target

A2Z Cust2Mate Solutions Reveals Aggregate $12.5M Registered Direct Offering, Priced At $6.40 Per Share, With No Warrants

Morgan Stanley analyst James Faucette upgrades TaskUs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TASK#NASDAQ">TASK</a>) from Equal-Weight to Overweight and raises the price target from $18 to $21.

Upgrades

TASK

Morgan Stanley Upgrades TaskUs to Overweight, Raises Price Target to $21

Biotech

Health Care

Financing

Offerings

General

Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross Proceeds Of $30M

Wells Fargo analyst Stephen Baxter upgrades Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) from Underweight to Equal-Weight and raises the price target from $101 to $127.

Wells Fargo Upgrades Cardinal Health to Equal-Weight, Raises Price Target to $127

CLSK

CleanSpark Announced The Pricing Of Its Offering Of $550M Aggregate Principal Amount Of 0.00% Convertible Senior Notes Due 2030

This special dividend is payable on January 15, 2025 to shareholders of record on January 3, 2025 and&nbsp;will return approximately $500 million to shareholders.

Dividends

Old Republic International Declares Special Cash Dividend Of $2.00 Per Share

Morgan Stanley analyst Andrew Galler downgrades Immunocore Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) from Overweight to Equal-Weight and lowers the price target from $74 to $35.

Downgrades

IMCR

Morgan Stanley Downgrades Immunocore Hldgs to Equal-Weight, Lowers Price Target to $35

UBS analyst A.J. Rice upgrades Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) from Neutral to Buy and raises the price target from $79 to $80.

UBS Upgrades Centene to Buy, Raises Price Target to $80

Morgan Stanley analyst Jeffrey Hung downgrades Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) from Overweight to Equal-Weight and lowers the price target from $17 to $12.

FOLD

Morgan Stanley Downgrades Amicus Therapeutics to Equal-Weight, Lowers Price Target to $12

Barclays analyst Brandt Montour downgrades Viking Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) from Overweight to Equal-Weight and maintains the price target from $49 to $49.

Barclays Downgrades Viking Holdings to Equal-Weight, Maintains Price Target to $49

Kimco Realty Reveals Final Results Of Cash Tender Offer To Purchase All Of Its Outstanding Depositary Shares Representing 1/1,000 Of A Share Of 7.25% Class N Cumulative Convertible Perpetual Preferred Stock And Consent Solicitation

BTIG analyst Justin Zelin initiates coverage on Enliven Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVN#NASDAQ">ELVN</a>) with a Buy rating and announces Price Target of $42.

Initiation

ELVN

BTIG Initiates Coverage On Enliven Therapeutics with Buy Rating, Announces Price Target of $42

U.S. stock futures advanced on Friday in premarket hours after declining in trade on Thursday. The futures of all four major indices were trading higher.
The 10-year and two-year Treasury notes yielded 4.33% and 4.19%, respectively. Traders await the import price index data, which will be released later today.
Wall Street is waiting for the Federal Reserve&#8217;s policy meeting next week. Federal Reserve officials are currently in a quiet period ahead of their December meeting.
November inflation data was in line with analyst expectations, shooting up the probability of a further 25 basis point rate cut in December rose to 96.7% versus 86% probability a week ago, according <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">to</a> CME Group&#8217;s FedWatch tool.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.65%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.33%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.23%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.29%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.41% to $606.79&nbsp;and the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) jumped 0.76% to $530.49, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Cues From The Last Session
<a href="https://www.benzinga.com/news/earnings/24/12/42478606/dow-dips-more-than-200-points-following-inflation-data-nvidia-and-amd-decline-fear-greed-index-remains-in-neutral-zone">U.S. stocks closed lower</a> on Thursday, with the Dow Jones shedding over 200 points. The market reacted to fresh inflation data and weaker-than-expected guidance from tech giants.
Technology stocks were among the day&#8217;s biggest losers. Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares dipped over 1%, while Adobe Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) plummeted more than 13% after issuing a disappointing 2025 outlook.
On the economic front, initial jobless claims rose to 242,000, higher than the estimated 220,000. Core producer prices increased by 0.2% month-over-month, aligning with market expectations.
Most S&amp;P 500 sectors ended the day in the red, with healthcare, consumer discretionary, and communication services bearing the brunt of the decline.
However, consumer staples bucked the trend and closed higher.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.66%</td>
<td>19.902.84</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.54%</td>
<td>6,051.25</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.53%</td>
<td>43,914.12</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.38%</td>
<td>2,361.08</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Picking up from Thursday&#8217;s session, Jason Goepfert, the founder of SentimenTrader, said, &#8220;This will be the S&amp;P 500&#8217;s 9th consecutive session with negative breadth. That&#8217;s happened fewer than 20 times in ~70 years. On average, the S&amp;P has been -12% from its high during these streaks.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This will be the S&amp;P 500&#39;s 9th consecutive session with negative breadth. That&#39;s happened fewer than 20 times in ~70 years. On average, the S&amp;P has been -12% from its high during these streaks. Today marks the closest the S&amp;P has been to its high. The 2 most similar were Dec… <a href="https://t.co/rxHkoG1AzD">pic.twitter.com/rxHkoG1AzD</a>
&mdash; Jason Goepfert (@jasongoepfert) <a href="https://twitter.com/jasongoepfert/status/1867309528573956329?ref_src=twsrc%5Etfw">December 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Talking about the future of AI, BlackRock in their 2025 outlook said, &#8220;We think the AI mega force will benefit U.S. stocks more and that's why we stay overweight, particularly relative to international peers such as European stocks.&#8221;
The note added that the &#8220;key signposts&#8221; for them to change their views will include any &#8220;surge in long-term bond yields or an escalation in trade protectionism.&#8221;
The note also added that BlackRock has conviction in U.S. equities outperforming their international peers. &#8220;We recognize valuations are rich in U.S. equities but don't see them as a near-term market driver,&#8221; it added.
According to Charles Schwab&#8217;s 2025 outlook, the volatility backdrop is likely to be different from what investors got used to in 2024. &#8220;The likelihood of a similar dynamic in 2025 is low, in our opinion,&#8221; the note said.
&#8220;Starting with where we are now, though, the market is in a relatively healthy position. As shown in the chart below, the S&amp;P 500 is comfortably above its 50 and 200-day moving averages; and when its 50 DMA was above its 200 DMA historically, the average annualized gain for the index (going back to the late 1920s) was 9.2%. There is strong momentum heading into the new year.&#8221;
However, &#8220;If inflation volatility picks back up, which will become clearer after tariff and labor policy implementations, there could be more risks to stocks via bonds,&#8221; Schwab note adds.
See Also:&nbsp;<a href="https://www.benzinga.com/money/how-to-trade-futures" target="_blank" rel="noreferrer noopener">How To Trade Futures</a>
Upcoming Economic Data
<ul>
<li>On Friday, the import price index data will be released at 8:30 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) was 14.38% up in premarket after it saw a four-fold increase in AI connectivity revenue driven by Tomahawk and Jericho shipments. The management also highlighted a significant reduction in VMware spending in the fourth quarter.</li>
<li>RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) was up 17.23% after it raised revenue guidance across the board based on current trends.</li>
<li>Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) was up 0.3% in premarket after it reported its first-quarter revenue and earnings per share, which beat analyst estimates.</li>
<li>Inovio Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) was down 22.61% after it announced a proposed public offering.</li>
<li>Loop Industries Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOOP#NASDAQ">LOOP</a>) gained 51.22% as completed convertible preferred financing with Reed Societe Generale Group.</li>
<li>Repare Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) tumbled 38.29% after it reported results of the Lunresertib and Camonsertib combination from MYTHIC Phase 1 gynecologic expansion clinical trial.</li>
<li>Candel Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAD#NASDAQ">CAD</a>) fell 31.12% after the company announced the pricing of its public offering.</li>
<li>Amentum Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTM#NYSE">AMTM</a>) was up 0.6% ahead of its earnings which are slated to be released before the opening bell. Analysts expect the company to report quarterly earnings at 25 cents per share.</li>
<li>Investors are awaiting earnings results from 51Talk Online Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COE#NYSE">COE</a>) today.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures rose in the early New York session by 1.19% to hover around $70.86 per barrel.
The gold spot index fell by 0.88% to $2,685.59 per ounce. The Dollar Index was up 0.01% to 106.964 level.
Most Asian markets declined on Friday including Australia&#8217;s ASX 200, Hong Kong&#8217;s Hang Seng, China&#8217;s CSI 300, and Japan&#8217;s Nikkei 225. India&#8217;s S&amp;P BSE Sensex and South Korea&#8217;s Kospi Index, bucked the trend as they advanced. Most European markets advanced.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42460199/jpmorgan-reiterates-underweight-rating-on-supermicro-maintains-the-lowest-target-price-among-the-17-tracked-analysts">SMCI Stock Receives Harshest Price Target Among 17 Tracked Analysts As JPMorgan Maintains Underweight Rating On Super Micro</a></li>
</ul>
Photo courtesy: Wikimedia

Equities

Market Summary

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADBE

AMTM

AVGO

COST

LOOP

NVDA

RPTX

US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focus

Barclays analyst Brandt Montour upgrades Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) from Equal-Weight to Overweight and raises the price target from $28 to $32.

NCLH

Barclays Upgrades Norwegian Cruise Line to Overweight, Raises Price Target to $32

Barclays analyst Brandt Montour upgrades Marriott Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>) from Equal-Weight to Overweight and raises the price target from $97 to $116.

Barclays Upgrades Marriott Vacations to Overweight, Raises Price Target to $116

Elon Musk has refuted reports that his AI venture, xAI, plans to use Sydney Sweeney&#8216;s voice for Grok&#8217;s advanced voice mode.
What Happened:&nbsp;On Friday, Musk responded to a post from Tech Dev Notes, which mentioned these rumors, with a simple &#8220;False.&#8221;
The post from Tech Dev Notes highlighted speculation about xAI&#8217;s intentions regarding Sweeney&#8217;s voice. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">False
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1867520193200861509?ref_src=twsrc%5Etfw">December 13, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/tech/24/12/42383967/how-to-use-apple-watch-as-a-digital-key-for-your-tesla-car?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">How To Use Apple Watch As A Digital Key For Your Tesla Car</a>
This interaction comes amid xAI&#8217;s recent announcement of raising $6 billion to expand its capabilities, including plans to significantly enhance its Colossus supercomputer.
Why It Matters: The denial from Musk is significant in the context of recent controversies surrounding the use of celebrity voices in AI technologies. Earlier this year,&nbsp;Scarlett Johansson&nbsp;was involved in a<a href="https://www.benzinga.com/general/entertainment/24/05/38956092/scarlett-johansson-gets-backing-from-actors-union-in-ai-voice-dispute-with-openai"> dispute with OpenAI</a> over similar concerns, highlighting the sensitivity around AI voice usage.
Musk&#8217;s xAI is positioning itself as a major player in the AI industry, challenging giants like&nbsp;Alphabet Inc. and&nbsp;Anthropic, backed by&nbsp;Jeff Bezos. The recent <a href="https://www.benzinga.com/tech/24/12/42358400/elon-musks-xai-raises-6b-for-the-2nd-time-this-year-as-it-looks-to-take-the-challenge-to-openai-google-and-jeff-bezos-backed-anthropic">$6 billion funding round</a> underscores xAI&#8217;s ambitions to expand its technological infrastructure and market influence.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42428505/google-asks-ftc-to-kill-microsofts-monopoly-over-hosting-openai-technology-on-its-cloud-servers-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Google Wants FTC To Dismantle Microsoft&#8217;s Exclusive Cloud Hosting Deal With OpenAI: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Tech

Elon Musk Denies xAI Licensing Sydney Sweeney's Voice For Grok's Advanced Mode

International Data Corp <a target="_blank" href="https://www.taipeitimes.com/News/biz/archives/2024/12/13/2003828402" rel="noreferrer noopener">told</a> the Taipei Times it expects Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to grow its revenue by ~25% in 2025, backed by <a target="_blank" href="https://www.benzinga.com/topic/ai" rel="noreferrer noopener">artificial intelligence (AI)</a> applications and crypto mining technologies.
IDC expects the global semiconductor industry <a target="_blank" href="https://www.idc.com/getdoc.jsp?containerId=prAP52837624" rel="noreferrer noopener">to grow by 15%</a> and the international foundry market to rise by 20% in 2025.
IDC&#8217;s projections imply that the contract chipmaker will command a 67% share of the global foundry market in 2025, up 300 bps year over year.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42464642/synopsys-to-divest-units-including-ansys-powerartist-to-secure-eu-approval-for-35-billion-deal" rel="noreferrer noopener">Synopsys Proposes Divesting Units, Including Ansys PowerArtist, For $35 Billion EU Deal Approval</a>
In the broader foundry definition, Taiwan Semiconductor could expand its market share to 36% in 2025 from 33% in 2024, IDC told the Taiwan Times.
Zeng told the Taipei Times that the contract chipmaker is fast-tracking production of 3-nm, 4-nm, and 5-nm chips by the shortest production cycle to accomplish the demand frenzy. The utilization rate of those technology nodes crossed the 95% mark.
Zeng said Taiwan Semiconductor targets adding 70,000 advanced wafers a month to its existing capacity for 2-nm, 3-nm, 4-nm, and 5-nm chips in 2025.
IDC expects the Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) supplier to double its capacity of advanced packaging technology, or chip-on-wafer-on-silicon (CoWoS), to double to 660,000 units in 2025 from 330,000 units in 2024.
IDC cited Taiwan Semiconductor commencing volume production of 2-nm technology in the second half of 2025, with a small volume shipped to Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) by 2026.
Taiwan Semiconductor&#8217;s November 2024 revenue grew 34% <a target="_blank" href="https://www.benzinga.com/24/12/42413866/taiwan-semiconductor-surges-34-in-november-strengthened-by-ai-and-smartphone-demand" rel="noreferrer noopener">to $8.55 billion</a>. The company&#8217;s market share grew&nbsp;to 64.9%, up from 62.3% sequentially, thanks to the smartphone and AI-related&nbsp;demand for its 3-nm and 5-nm technologies.
Taiwan Semiconductor stock surged 89% year-to-date.
Price Action: TSM stock is up 2.21% at $195.70 premarket at the last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42468172/box-inc-positioned-for-ai-monetization-analyst-predicts-upside" target="_blank" rel="noreferrer noopener">Box Undervalued? Analyst Flags Overly Pessimistic Views Amid AI Monetization Push</a></li>
</ul>
Photo by Sundry Photography on Shutterstock

Emerging Markets

Media

AAPL

Taiwan Semiconductor Set to Command 67% Foundry Market Share By 2025: IDC

B of A Securities analyst Ross Fowler reinstates Southwest Gas Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWX#NYSE">SWX</a>) with a Underperform and announces $73 price target.

B of A Securities Reinstates Underperform on Southwest Gas Hldgs, Announces $73 Price Target

B of A Securities analyst Bryan Spillane upgrades General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) from Neutral to Buy and raises the price target from $78 to $80.

B of A Securities Upgrades General Mills to Buy, Raises Price Target to $80

Earnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Upexi (NASDAQ:<a href="https://investorplace.com/stock-quotes/upxi-stock-quote/">UPXI</a>) just reported results for the third quarter of 2024.<ul><li>Upexi reported earnings per share of -20 cents. This was below the analyst estimate for EPS of -10 cents.</li><li>The company reported revenue of $14.45 million.</li><li>This was 34.34% worse than the analyst estimate for revenue of $22.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/07/upxi-stock-earnings-upexi-for-q3-of-2024/">UPXI Stock Earnings: Upexi Misses EPS, Misses Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

UPXI Stock Earnings: Upexi Misses EPS, Misses Revenue for Q3 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday!



Moving stocks this morning are ongoing market volatility, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) stock is rocketing more than 100% alongside heavy pre-market trading.</li>



<li>VBI Vaccines (NASDAQ:<a href="https://investorplace.com/stock-quotes/vbiv-stock-quote/">VBIV</a>) shares are soaring over 72% after a <a href="https://www.nasdaq.com/press-release/vbi-vaccines-provides-update-its-restructuring-proceedings-2024-08-02">bankruptcy filing last week</a>.</li>



<li>Lumen Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/lumn-stock-quote/">LUMN</a>) stock is surging more than 47% after announcing a <a href="https://www.prnewswire.com/news-releases/ai-demand-drives-5-billion-in-new-business-and-massive-expansion-of-the-internet-302214737.html">$5 billion artificial intelligence (AI) deal</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are gaining over 32% with strong early morning trading today.</li>



<li>Agape ATP (NASDAQ:<a href="https://investorplace.com/stock-quotes/atpc-stock-quote/">ATPC</a>) stock is increasing more than 31% with heavy early morning trading.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) shares are rising over 29% without any clear news this morning.</li>



<li>AgriFORCE Growing Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/agri-stock-quote/">AGRI</a>) stock is climbing more than 21% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318495930&amp;type=PDF&amp;symbol=AGRI&amp;cdn=deb75fb21f6e866090c8f87065ebe74c&amp;companyName=AgriFORCE++Growing+Systems+Ltd.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-08-05">plans to regain listing compliance</a>.</li>



<li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) shares are heading 20% higher as it rebounds from a fall yesterday.</li>



<li>RxSight (NASDAQ:<a href="https://investorplace.com/stock-quotes/rxst-stock-quote/">RXST</a>) stock is jumping over 18% after beating Q2 estimates and increasing its guidance.</li>



<li>Beyond Air (NASDAQ:<a href="https://investorplace.com/stock-quotes/xair-stock-quote/">XAIR</a>) shares are up more than 17% despite a lack of news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) stock is plummeting over 28% after <a href="https://finance.yahoo.com/news/former-manufacturing-giant-sunpower-files-014238292.html">filing for bankruptcy</a>.</li>



<li>Aqua Metals (NASDAQ:<a href="https://investorplace.com/stock-quotes/aqms-stock-quote/">AQMS</a>) shares are diving more than 23% with the release of its <a href="https://ir.aquametals.com/press-releases/detail/301/aqua-metals-announces-continued-progress-on-sierra-arc">Q2 earnings report</a>.</li>



<li>CervoMed (NASDAQ:<a href="https://investorplace.com/stock-quotes/crvo-stock-quote/">CRVO</a>) stock is tumbling over 20% following a rally yesterday.</li>



<li>Helport AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/hpai-stock-quote/">HPAI</a>) shares are taking a more than 19% beating after <a href="https://www.stocktitan.net/news/HPAI/helport-ai-limited-and-tristar-acquisition-i-corp-announce-closing-l28l2mpn3gqu.html">recently going public</a>.</li>



<li>Chegg (NYSE:<a href="https://investorplace.com/stock-quotes/chgg-stock-quote/">CHGG</a>) stock is sliding over 18% after <a href="https://www.marketwatch.com/story/chegg-shares-tumble-after-education-tech-company-swings-to-2q-loss-f11b00a6">reporting a Q2 loss</a>.</li>



<li>Notable Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntbl-stock-quote/">NTBL</a>) shares are decreasing more than 18% without any clear news.</li>



<li>Upexi (NASDAQ:<a href="https://investorplace.com/stock-quotes/upxi-stock-quote/">UPXI</a>) stock is falling over 15% after <a href="https://www.nasdaq.com/press-release/upexi-provides-shareholder-update-restructuring-reduce-debt-and-increase-working">announcing restructuring plans</a>.</li>



<li>ZoomInfo Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/zi-stock-quote/">ZI</a>) shares are dropping more than 15% <a href="https://www.investing.com/news/stock-market-news/zoominfo-stock-tumbles-on-weak-guidance-cfo-transition-3555565">on a weak guidance</a>.</li>



<li>EpicQuest Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/eeiq-stock-quote/">EEIQ</a>) stock is dipping over 15% despite a lack of obvious news this morning.</li>



<li>Jumia Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/jmia-stock-quote/">JMIA</a>) shares close out our pre-market stock movers down 15% <a href="https://www.nasdaq.com/press-release/jumia-announce-second-quarter-2024-results-august-6-2024-2024-07-22">ahead of its Q2 earnings report</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-aug-6th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Earnings week ahead: JPMorgan, Wells Fargo, PepsiCo, Delta Air Lines, and more

Upexi to take action against apparent stock manipulation of fractional share roundup with reverse stock split

10:52 EDT Upexi (UPXI) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try No...

Upexi trading resumes

10:47 EDT Upexi (UPXI) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaki...

Upexi trading halted, volatility trading pause

Upexi receives non-compliance notice from Nasdaq stock market

Upexi (UPXI) received a Non Compliance Letter from The Nasdaq Stock Market due to the Company's failure to timely file its Form 10-Q Quarterly Repo...

Upexi receives non-compliance notice from Nasdaq

Upexi (UPXI) has filed a complaint in the United States District Court for the District of Nevada to pursue the groups and individuals who orchestr...

Upexi files litigation over 'manipulation of fractional share roundups'

ACCD

AEHR

AFAR

AGRI

AIRE

APLD

ATPC

BSET

BSVN

BYRN

CCEL

CHGG

CRVO

DOGZ

EDUC

EEIQ

EPAC

ERIC

ETWO

EVGR

FAST

FNGR

GDST

HELE

HIFS

HPAI

IMMP

JMIA

KRUS

LEDS

LEXX

LUMN

MANU

NAPA

NEOG

NRIX

NTBL

NTIC

NVOS

PCYO

PRST

PRTG

PSMT

RELL

RXST

SPWR

STBX

TLRY

UPXI

USGO

VBIV

VIST

VLGEA

VOXX

WAFD

WDFC

WKEY

XAIR

Press Releases

Upexi Provides Shareholders with Update on Restructuring to Reduce Debt and Increase Working Capital through Sale of Assets

Upexi Provides Update on Filing Form 10Q for March 31, 2024

Upexi to File Form 10-Q on July 8th

Earnings

Upexi Reports Fiscal Third Quarter 2024 Financial Results

Upexi Provides Shareholder Update on Restructuring to Reduce Debt and Increase Working Capital

Upexi to File Form 10-K on November 1st and Regains Compliance with Nasdaq Minimum Bid Price Rule

Legal

Upexi to Take Action Against Apparent Stock Manipulation of Fractional Share Roundup with Reverse Stock Split

Upexi Recieves Notice from The Nasdaq Stock Market

Upexi Files litigation in Nevada as first Step in Determining Manipulation of Fractional Share Roundups during Reverse Stock Split

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

Comments

Upexi

Upexi (UPXI) Opciones

Upexi (NASDAQ:UPXI) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL